Shares of BioNTech SE (FRA: 22UA) surged 13% on Monday after reports that the biotech firm is in talks with the European Union over a potential deal for its COVID-19 vaccines.
Media outlets reported yesterday that the EU is holding advanced talks with a group of drugmakers, namely Moderna, Sanofi, Johnson & Johnson, BioNtech, and CureVac.
“We are in talk with several companies on possible COVID-19 vaccines,” a spokesman for the Commission said.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Last month, the EU ordered 400 million doses of the potential COVID-19 vaccine from AstraZeneca. The EU agreed to pay upfront for the vaccines.
According to the reports, talks with Johnson & Johnson are centered around the purchase of 200 million doses of vaccine.
BioNTech declined to comment on the reports, although Sanofi confirmed the talks about the potential deal for 300 million doses.
The European Union already offered funds to BioNTech to ramp up the development of its vaccine. The Germany-based company is working on a new vaccine with U.S. pharma giant Pfizer. These two firms are working to produce and deliver 100 million doses by the end of the year.
BioNTech share price is trading more than 12% higher in Germany today as the buyers work to extend the bullish move.
